0001104659-22-086715.txt : 20220805 0001104659-22-086715.hdr.sgml : 20220805 20220805161735 ACCESSION NUMBER: 0001104659-22-086715 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220803 FILED AS OF DATE: 20220805 DATE AS OF CHANGE: 20220805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brzeczko Albert W CENTRAL INDEX KEY: 0001455740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 221141092 MAIL ADDRESS: STREET 1: C/O ACURA PHARMACEUTICALS, INC. STREET 2: 660 N. NORTH COURT CITY: PALATINE STATE: IL ZIP: 60067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0000786947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 110853640 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 CITY: PALATINE STATE: IL ZIP: 60067 BUSINESS PHONE: 847-705-7709 MAIL ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 STREET 2: . CITY: PALATINE STATE: IL ZIP: 60067 FORMER COMPANY: FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW DATE OF NAME CHANGE: 19920703 4 1 tm2222620-4_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-08-03 0 0000786947 ACURA PHARMACEUTICALS, INC ACUR 0001455740 Brzeczko Albert W C/O ACURA PHARMACEUTICALS, INC. 616 N. NORTH COURT SUITE 120 PALATINE IL 60067 0 1 0 0 VP, Pharma Sciences - APT Common Stock 2022-08-03 4 M 0 43333 A 412001 D Restricted Stock Unit (2017 Plan) 0.01 2022-08-03 4 M 0 9333 A Common Stock 9333 108000 D Restricted Stock Unit (2017 Plan) 0.01 2022-08-03 4 M 0 34000 A Common Stock 34000 74000 D Represents exchange of restricted stock units. Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock. Does not include Restricted Stock Units. Not Applicable. 28,000 Restricted Stock Units were granted on December 11, 2017 and were 100% vested on December 11, 2018. Distributions in respect of this vested Restricted Stock Units will be made in three equal installments in each of 2020, 2021, and 2022 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code. 102,000 Restricted Stock Units were granted on December 11, 2018 and were 100% vested on December 11, 2019. Distributions in respect of this vested Restricted Stock Units will be made in three equal installments in each of 2021, 2022, and 2023 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code. /s/ Albert W. Brzeczko 2022-08-04